Clinical trial
Does Less Invasive Surfactant Administration (LISA) During High-flow Nasal Cannula Oxygen Treatment Reduces the Need for Invasive Ventilation in Late Preterm and Term Born Infants With Respiratory Distress?
NCT06421506 is registered in ClinicalTrials.gov with King's College Hospital NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Less Invasive Surfactant Administration (LISA) During High-flow Nasal Cannula Oxygen Treatment Reduces the Need for Invasive Ventilation in Late Preterm and Term Born Infants With Respiratory Distress?
- Lead sponsor
- King's College Hospital NHS Trust
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 8, 2024
- Completion date
- September 30, 2027
- Enrollment
- 245 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
preterm pregnancy, respiratory distress syndrome, surfactant deficiency syndrome neonatal